Clinical Trial

Effect of Contralateral NMES on Quadriceps Activation After ACL Injury or Surgery

Study acronym: ACLQuadAct
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
A major complication after cruciate ligament injury and surgery is arthrogenic muscle inhibition of the quadriceps, which is characterised by a deficit in voluntary muscle activation in the affected leg. This can hinder rehabilitation processes, lead to impaired knee function, and negatively impact the patients' quality of life. The primary objective of this study is to assess whether voluntary quadriceps activation on the injured side is facilitated by the concomitant application of neuromuscular electrical stimulation (NMES) on the contralateral quadriceps.
Trial Details
NCT Number NCT07156734
Lead Sponsor Schulthess Klinik
Conditions ACL Injury
Enrollment 25 participants
Start Date 2025-09
Primary Completion 2026-05 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-05